𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CD8+ T-cell response to survivin is a marker of effective immune priming in a neuroblastoma vaccine strategy

✍ Scribed by Felix C. Blanco; Priya Srinivasan; Ryan M. Walk; Jason A. Snyder; Lina Chakrabarti; Stanislav Vukmanovic; Anthony D. Sandler

Book ID
113680710
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
51 KB
Volume
213
Category
Article
ISSN
1072-7515

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Stimulation of CD8+ T cell responses to
Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine
✍ Sandra R. Reynolds; Ruth Oratz; Richard L. Shapiro; Phyllis Hao; Zhang Yun; Mari 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 85 KB

A critical requirement for cancer vaccines is that they stimulate CD8 ؉ T cell responses. In this study, we tested the ability of a polyvalent melanoma vaccine to induce CD8 ؉ T cell responses to the melanoma associated antigens MAGE-3 and Melan A/MART-1. Fifteen HLA-A2 ؉ patients with resected mali

Altered primary CD8+ T cell response to
Altered primary CD8+ T cell response to a modified virus Ankara(MVA)-vectored vaccine in the absence of CD4+ T cell help
✍ Marie J. Estcourt; Andrew J. McMichael; Tomáš Hanke 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 1 views

## Abstract T cell receptor‐transgenic F5 mice were used to assess primary CD8^+^ T cell responses to a modified virus Ankara (MVA)‐vectored vaccine in the absence of CD4^+^ T cell help. Naive, CD8‐enriched, CFSE‐labelled F5 cells were transferred into normal or CD4^+^ cell‐depleted mice and the mi